TORONTO, Aug. 24 /CNW/ - Prollenium and Canderm GP, an affiliate of
sanofi-aventis Canada, have entered into a supply and distribution
partnership for Ovita HV, a Hyaluronic Acid (HA) based dermal filler.
Ovita is based on the highly successful Revanesse Family of Products
approved for use in Canada and available in over 70 countries spanning
North America, Europe, Asia-Pacific, South America and the Middle East.
"Prollenium is excited to be the partner of choice for Canderm
GP in this endeavor. We have been working hard to expand our business
globally and this relationship with a long-standing and reputable
company like Canderm is a strong and positive step towards expanding our
sales and increasing the number of physicians who are using our complete
line of products. Working with one of the largest dermatology focused
companies in Canada further enhances our network," says Ario
Khoshbin, President of Prollenium Medical Technologies.
Ovita HV is a biodegradable, non animal-based,
clear HA gel made using Prollenium's¨ patented cross-linking process.
This process creates a high quality, safe, long lasting dermal filler.
Founded in 2002, Prollenium Medical
Technologies, Inc is headquartered in Aurora, Ontario. The company is
widely recognized as a leading manufacturer of medical devices used in
cosmetic and plastic surgery treatments worldwide. The company's
flagship REVANESSE™ product line (www.revanesse.com) is widely used to
erase facial lines and wrinkles, smooth deep folds and give lips a
natural fuller look. For more information, visit www.prollenium.com
Canderm GP, an affiliate of sanofi-aventis
Canada, is one of Canada's leading skin care companies. The company has
built this reputation over several decades with a portfolio of
innovative products acquired through both internal development and
partner sourcing. The company's skin care product range includes
cosmeceutical products, physician-practiced cosmetic procedures,
physician-recommended dermatological products, and over-the-counter
products. Canderm also offers a full range of injectable dermal filler
products. For more information, visit www.canderm.com
SOURCE Prollenium Medical Technologies Inc.
For further information: For further information: